Engility Holdings Merges with SAIC for $2.5 Billion

We represented Engility Holdings (NYSE: EGL) in its merger with Science Applications International Corp. (NYSE: SAIC) in which SAIC acquired Engility in an all-stock transaction valued at $2.5 billion. With two highly complementary portfolios, the transaction creates market sub-segment scale in strategic business areas of national interest, such as defense, federal civilian agencies, intelligence, and space. In addition, it expands the capabilities of both companies, bringing additional systems engineering, mission, and IT capabilities to a broader base of customers. The combined company ranks as the second largest independent technology integrator in government services.

Engility Holdings, Inc. is a pure-play government services contractor providing highly skilled personnel wherever, whenever they are needed in a cost-effective manner.

SAIC is a premier technology integrator providing full life cycle services and solutions in the technical, engineering, intelligence, and enterprise information technology markets.

This transaction was named a winner in the “Industrials Deal of the Year (Over $1B),” category for the 18th Annual M&A Advisor Awards in 2019. In addition, it had been named a finalist in the “Corporate/Strategic Deal of the Year ($1B-$5B)” and “Private Equity Deal of the Year (Over $1B)” categories. Bass, Berry & Sims had six separate deals recognized as finalists among nine categories for the 2019 M&A Advisor Awards.

You Also May Be Interested In:

  • Representation of AutoZone, Inc. (NYSE: AZO) in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000% Senior Notes due 2030

    We represented AutoZone, Inc. in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000%...
    Client Type: Public Company
  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Client Type: Private Company